Attached files

file filename
EX-12.1 - EX-12.1 - CSX CORPd527232dex121.htm
EX-5.1.2 - EX-5.1.2 - CSX CORPd527232dex512.htm
EX-5.1.1 - EX-5.1.1 - CSX CORPd527232dex511.htm
EX-4.4 - EX-4.4 - CSX CORPd527232dex44.htm
EX-4.3 - EX-4.3 - CSX CORPd527232dex43.htm
EX-4.2 - EX-4.2 - CSX CORPd527232dex42.htm
EX-4.1 - EX-4.1 - CSX CORPd527232dex41.htm
EX-1.1 - EX-1.1 - CSX CORPd527232dex11.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 15, 2018

 

 

CSX CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Virginia   1-08022   62-1051971

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

500 Water Street, 15th Floor, Jacksonville, Florida   32202
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (904) 359-3200

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01. Entry into a Material Definitive Agreement

On February 15, 2018, CSX Corporation (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and UBS Securities LLC, as representatives of the Underwriters named therein (the “Underwriters”) for the public offering of $800,000,000 aggregate principal amount of the Company’s 3.800% Notes due 2028, $850,000,000 aggregate principal amount of the Company’s 4.300% Notes due 2048 and $350,000,000 aggregate principal amount of the Company’s 4.650% Notes due 2068 (collectively, the “Notes”). The Notes were issued pursuant to an indenture, dated as of August 1, 1990, between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), successor to JPMorgan Chase Bank, N.A. (formerly known as The Chase Manhattan Bank), as trustee, as supplemented by a First Supplemental Indenture dated as of June 15, 1991, a Second Supplemental Indenture dated as of May 6, 1997, a Third Supplemental Indenture dated as of April 22, 1998, a Fourth Supplemental Indenture dated as of October 30, 2001, a Fifth Supplemental Indenture dated as of October 27, 2003, a Sixth Supplemental Indenture dated as of September 23, 2004, a Seventh Supplemental Indenture dated as of April 25, 2007 and an Eighth Supplemental Indenture dated as of March 24, 2010 (collectively, the “Indenture”), and an Action of Authorized Pricing Officers dated as of February 15, 2018. The Notes have been registered under the Securities Act of 1933, as amended (the “Act”), by a Registration Statement on Form S-3ASR (Registration No. 333-209541) which became effective February 12, 2016. On February [16], 2018, the Company filed with the Securities and Exchange Commission, pursuant to Rule 424(b)(2) under the Act, its Prospectus, dated February 12, 2016, and Prospectus Supplement, dated February 15, 2018, pertaining to the offering and sale of the Notes.

The forms of the Notes are filed as Exhibits 4.2, 4.3 and 4.4 to this Report and are incorporated by reference in this Report.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

See Item 1.01.

 

Item 9.01. Financial Statements and Exhibits

 

  (d) Exhibits required to be filed by Item 601 of Regulation S-K.

The following exhibits are filed as a part of this Report.

 

Exhibit
No.
  

Description

  1.1    Underwriting Agreement, dated February 15, 2018, among CSX Corporation and Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley  & Co. LLC and UBS Securities LLC, as representatives of the Underwriters named therein.
  4.1    Action of Authorized Pricing Officers of CSX Corporation dated February 15, 2018.
  4.2    Form of 2028 Notes.
  4.3    Form of 2048 Notes.
  4.4    Form of 2068 Notes.
  5.1.1    Opinion of Davis Polk & Wardwell LLP.
  5.1.2    Opinion of Hunton & Williams LLP.
12.1    Computation of Ratio of Earnings to Fixed Charges.
23.1.1    Consent of Davis Polk & Wardwell LLP (included in Exhibit 5.1.1).
23.1.2    Consent of Hunton & Williams LLP (included in Exhibit 5.1.2).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    CSX CORPORATION
Date: February 20, 2018     By:  

/s/ Sean Pelkey

    Name:   Sean Pelkey
    Title:   Vice President - Treasurer